Pharmaceuticals,
Journal Year:
2022,
Volume and Issue:
15(7), P. 892 - 892
Published: July 19, 2022
Pain
and
itch
are
both
important
manifestations
of
various
disorders,
such
as
herpes
zoster,
atopic
dermatitis,
psoriasis.
Growing
evidence
suggests
that
sensations
have
shared
mediators,
overlapping
neural
circuitry,
similarities
in
sensitization
processes.
In
fact,
pain
coexist
some
disorders.
Determining
pharmaceutical
agents
targets
for
treating
concurrently
is
scientific
clinical
relevance.
Here
we
review
the
neurobiology
discuss
well
novel
compounds
effective
concurrent
treatment
these
sensations.
Advanced Science,
Journal Year:
2024,
Volume and Issue:
11(15)
Published: Feb. 13, 2024
Abstract
Various
disorders
are
accompanied
by
histamine‐independent
itching,
which
is
often
resistant
to
the
currently
available
therapies.
Here,
it
reported
that
pharmacological
activation
of
Slack
(Kcnt1,
K
Na
1.1),
a
potassium
channel
highly
expressed
in
itch‐sensitive
sensory
neurons,
has
therapeutic
potential
for
treatment
itching.
Based
on
Slack‐activating
antipsychotic
drug,
loxapine,
series
new
derivatives
with
improved
pharmacodynamic
and
pharmacokinetic
profiles
designed
enables
validate
as
target
vivo.
One
these
activators,
compound
6,
exhibits
negligible
dopamine
D
2
3
receptor
binding,
unlike
loxapine.
Notably,
6
displays
potent
on‐target
antipruritic
activity
multiple
mouse
models
acute
chronic
itch
without
motor
side
effects.
These
properties
make
lead
molecule
development
therapies
targeting
Slack.
Journal of Medical Virology,
Journal Year:
2024,
Volume and Issue:
96(6)
Published: June 1, 2024
Previous
research
has
not
investigated
the
persistent
cutaneous
immune-related
adverse
events
(cirAEs)
related
to
long
COVID
investigate
long-term
sequelae.
This
multinational
study,
using
a
propensity-matched
overlap
weighting
method,
utilizes
large
national
claims-based
cohorts,
ICD-10
code
diagnosis,
focusing
on
patients
aged
≥20
years
from
three
countries:
South
Korean,
Japanese,
and
British
cohorts.
To
estimate
risk
of
cirAEs
in
COVID,
persistence
or
emergence
occurring
4
weeks
after
initial
SARS-CoV-2
infection,
we
employed
Cox
proportional
hazard
regression
model.
The
Korean
cohort
(n
=
5,937,373;
mean
age
49.2
[SD:
13.2]),
Japanese
4,307,587;
42.5
[13.6]),
UK
395,435;
71.0
[8.07])
were
presented.
An
increased
was
observed
(HR,
1.10;
95%
CI,
1.06-1.14)
cohort,
while
similar
association
higher
more
severe
COVID-19
cases
(1.31;
1.22-1.39).
Unlike
vaccination
attenuated
risk,
especially
with
two
doses
(1.03;
0.95-1.11)
heterologous
regimens
(0.98;
0.76-1.27).
time
attenuation
effect
indicated
sustained
for
up
6
months
postinfection
(<3
months:
1.13
[1.07-1.19];
3-6
1.14
[1.06-1.22]).
infection
is
associated
an
aspect
COVID.
Vaccination
might
reduce
this
highlighting
need
preventive
strategies
management.
Science Advances,
Journal Year:
2024,
Volume and Issue:
10(39)
Published: Sept. 25, 2024
Itch
is
a
protective
sensation
that
drives
scratching.
Although
specific
cell
types
have
been
proposed
to
underlie
itch,
the
neural
basis
for
itch
remains
unclear.
Here,
we
used
two-photon
Ca
2+
imaging
of
dorsal
horn
visualize
neuronal
populations
are
activated
by
itch-inducing
agents.
We
identify
convergent
population
spinal
interneurons
recruited
diverse
itch-causing
stimuli
represents
subset
neurons
express
gastrin-releasing
peptide
receptor
(GRPR).
Moreover,
find
conveyed
brain
via
GRPR-expressing
output
target
lateral
parabrachial
nuclei.
then
show
kappa
opioid
agonist
nalfurafine
relieves
selectively
inhibiting
GRPR
spinoparabrachial
neurons.
These
experiments
provide
population-level
view
respond
pruritic
stimuli,
pinpoint
convey
brain,
and
cellular
agonists
inhibition
itch.
European journal of medical research,
Journal Year:
2023,
Volume and Issue:
28(1)
Published: Feb. 2, 2023
Abstract
Purpose
The
without
a
time
limitation.
Most
recent
search
was
performed
on
1st
June
2022.
Results
Thorough
history
and
physical
examination
are
very
important
in
view
of
multiple
possible
causes
anal
pruritus.
the
focus
during
is
drawn
to
perianal
region.
A
digital
rectal
an
anoscopy
essential.
It
necessary
aim
this
narrative
review
overview
classification,
diagnostics,
treatment
options
future
perspective
Methods
by
two
authors
(AD
MJ)
independently
following
electronic
databases:
PubMed,
EMBASE,
Web
Science,
Cochrane
Library,
CENTRAL
Allied
Complementary
Medicine
Databases
(AMED).
Search
restricted
English
language
only
avoid
moisture
use
soaps
Furthermore,
patient
should
certain
foods
increase
intake
fiber.
If
symptoms
do
not
resolve,
topical
steroids,
capsaicin
(0.006%)
tacrolimus
(0.1%)
ointments
may
be
used.
For
intractable
cases,
intradermal
methylene
blue
injection
might
give
long-lasting
symptom
relief.
Conclusion
Anal
pruritus
long-term
deteriorating
quality
life
issue.
it
with
difficult
diagnosis.
for
best
treatment.
Journal of Allergy and Clinical Immunology,
Journal Year:
2023,
Volume and Issue:
152(4), P. 927 - 932
Published: July 13, 2023
Therapies
specifically
targeting
nonhistaminergic
pruritus
are
largely
lacking.
Difelikefalin
(DFK)
has
been
found
to
reduce
itch
in
various
chronic
pruritic
conditions,
including
atopic
dermatitis
(AD).
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Jan. 27, 2023
Nociceptor
neurons
play
a
crucial
role
in
maintaining
the
body's
homeostasis
by
detecting
and
responding
to
potential
dangers
environment.
However,
this
function
can
be
detrimental
during
allergic
reactions,
since
vagal
nociceptors
contribute
immune
cell
infiltration,
bronchial
hypersensitivity,
mucus
imbalance,
addition
causing
pain
coughing.
Despite
this,
specific
mechanisms
which
acquire
pro-inflammatory
characteristics
reactions
are
not
yet
fully
understood.
In
study,
we
aimed
investigate
molecular
profile
of
airway
nociceptor
inflammation
identify
signals
driving
such
reprogramming.
Using
retrograde
tracing
lineage
reporting,
identified
unique
class
inflammatory
that
exclusively
innervate
airways.
ovalbumin
mouse
model
inflammation,
these
undergo
significant
reprogramming
characterized
upregulation
NPY
receptor